Use of Ramucirumab for Patients with Squamous or Nonsquamous Lung Cancer
1 Views
administrator
07/07/23
In this segment, Mark Socinski, MD, discusses how the approval of ramucirumab as second- and third-line therapy has advanced the treatment of metastatic lung cancer.
-
Category
Show more
Facebook Comments
No comments found